Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREEU pharma legislation
How can we ensure Europeans don't miss out on the latest advances in treatment?
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Statements & press releases 22.04.24
EFPIA Statement on the use of AI in the medicinal product lifecycle in the context of the AI Act
It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative,...
Read Article -
Statements & press releases 19.04.24
EFPIA swings behind Council’s call for a European Competitiveness Deal
Time to close the gap
Read Article -
Partner Event 03.05.24
Thought Leader Session: Collaborating for Change
Transforming Rare Disease Outcomes through Public-Private Partnerships.
View Event -
External Event 14.05.24
GetReal Conference 2024
A Growing Convergence: RWE for Regulatory and HTA Decision-Making
View Event -
Partner Event 15.05.24
12th European Conference on Rare Disease & Orphan Products
The ECRD is the largest, patient-led, rare disease policy-shaping event held in Europe.
View Event